Premium

Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016

Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license
Loading statistic...
BrandsBranded GenericsUnbranded Generics
----
----
----
----
----
----
----
----
----
----
----
----

© Statista 2017

Download Settings Share
Chart type
Datalabels
Share on Social Media
Description Source More information
This statistic compares brand drug prescription revenues of branded and unbranded generics in the United States from 2005 to 2015. In 2005, some 81 percent of total U.S. prescription revenues were made through brand name medications. However, this share decreased to some 71 percent in 2013, and increased slightly to over 74 percent in 2016. Generics are copies or equivalents of once patent protected drugs, containing the same active ingredient, in the same amount, in the same form, dissolving at the same rate in equal amounts like the original.
Show more
Release date
May 2017
Region
United States
Survey time period
2005 to 2016
Supplementary notes
Report reflects prescription-bound products including insulins and excluding other products such as OTC. Includes prescriptions and insulins dispensed by chain and independent pharmacies, food store pharmacies, mail service pharmacies, and long-term care facilities. Spending figures also include sales into hospitals, clinics, and other institutional settings. Prescription counts are not adjusted for length of therapy. 90-day and 30-day prescriptions are both counted as one prescription.
This statistic was assembled from several IMS Health/QuintilesIMS reports.

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "Generics and biosimilars"

  • Global overview
The most important statistics
  • Top companies
The most important statistics
  • U.S. market
  • Patent expiration
The most important statistics
  • Savings
The most important statistics
  • Biosimilars

Related Studies: Available to Download in PDF or PPTX Format

Generics and biosimilars

All Information
in one Presentation

Generics and biosimilars

Everything On "Generics and biosimilars" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions